Quantcast

Industry news that matters to you.  Learn more

Archives for February 2017

World-first Way to Fast-track Drugs for Killer Disease

Flinders University researchers are pioneering a new and simple test to pick up signals of Motor Neuron Disease in patients. The non-invasive urinary test has the potential to expedite the worldwide quest to develop better treatments, or even a cure, for the deadly neuro-degenerative disease. The test, under further development at Flinders University and the University of Miami, is set to be used in clinical trials looking for improved drug treatments for MND. The test measures a key protein biomarker found in the urine of MND sufferers as the disease progresses. The promising findings have been published in the high-profile international journal, Neurology, the medical journal of the American Academy of Neurology.

Novel Biomarker Predicts Treatment Response in Chronic Leukemia

A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia (CML), according to a Northwestern Medicine study.

Meso Scale Discovery Launches New V-PLEX Assays for Th17 Research

Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC. (MSD), recently launched V-PLEX® immunoassays validated for the detection of the biomarkers IL-17A, IL-21, IL-22, IL-23, IL-27, and MIP-3α in human cell culture supernatants, serum, plasma, and urine.

NIH Consortium Takes Aim at Vascular Disease-linked Cognitive Impairment and Dementia

To better predict, study, and diagnose small vessel disease in the brain and its role in vascular contributions to cognitive impairment and dementia (VCID), the National Institutes of Health has launched MarkVCID, a consortium designed to accelerate the development of new and existing biomarkers for small vessel VCID.

The five-year program, developed by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with the National Institute on Aging (NIA), consists of seven research groups across the United States working together via a coordinating center based at Massachusetts General Hospital, Boston. A kick-off meeting for the consortium was held immediately prior to the International Stroke Conference 2017 in Houston, Feb. 20-21.

Cocaine Addiction Leads to Build-up of Iron in Brain

Cocaine addiction may affect how the body processes iron, leading to a build-up of the mineral in the brain, according to new research from the University of Cambridge. The study, published today in Translational Psychiatry, raises hopes that there may be a biomarker – a biological measure of addiction – that could be used as a target for future treatments.